Anyone noticed the directors buying?
I wonder what is Andrew Kroger's endgame. He now has 25%. Will take him ages to do the creep at 3% per annum, so my main worry is private equity taking this away on the cheap. Heaps of cashflow, perfect candidate for PE to merge up with Cellcare, then hive off the blood cord operations separately and refloat the main business later on.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
75.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.60M | |||
| Open | High | Low | Value | Volume |
| 75.0¢ | 75.0¢ | 75.0¢ | $3.457K | 4.609K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 295 | 71.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.0¢ | 2057 | 1 |
View Market Depth
| Last trade - 11.57am 31/07/2025 (20 minute delay) ? |
| CTE (ASX) Chart |